» Articles » PMID: 33569079

Integrative Epigenomic Analysis of Transcriptional Regulation of Human CircRNAs

Overview
Journal Front Genet
Date 2021 Feb 11
PMID 33569079
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Circular RNAs (circRNAs) are evolutionarily conserved and abundant non-coding RNAs whose functions and regulatory mechanisms remain largely unknown. Here, we identify and characterize an epigenomically distinct group of circRNAs (TAH-circRNAs), which are transcribed to a higher level than their host genes. By integrative analysis of cistromic and transcriptomic data, we find that compared with other circRNAs, TAH-circRNAs are expressed more abundantly and have more transcription factors (TFs) binding sites and lower DNA methylation levels. Concordantly, TAH-circRNAs are enriched in open and active chromatin regions. Importantly, ChIA-PET results showed that 23-52% of transcription start sites (TSSs) of TAH-circRNAs have direct interactions with cis-regulatory regions, strongly suggesting their independent transcriptional regulation from host genes. In addition, we characterize molecular features of super-enhancer-driven circRNAs in cancer biology. Together, this study comprehensively analyzes epigenomic characteristics of circRNAs and identifies a distinct group of TAH-circRNAs that are independently transcribed via enhancers and super-enhancers by TFs. These findings substantially advance our understanding of the regulatory mechanism of circRNAs and may have important implications for future investigations of this class of non-coding RNAs.

Citing Articles

Circ_0003945: an emerging biomarker and therapeutic target for human diseases.

Zhang X, Ma L, Wan L, Wang H, Wang Z Front Oncol. 2024; 14:1275009.

PMID: 38711855 PMC: 11070578. DOI: 10.3389/fonc.2024.1275009.


Super-enhancers complexes zoom in transcription in cancer.

Wang M, Chen Q, Wang S, Xie H, Liu J, Huang R J Exp Clin Cancer Res. 2023; 42(1):183.

PMID: 37501079 PMC: 10375641. DOI: 10.1186/s13046-023-02763-5.


Circular RNAs in the Origin of Developmental Lung Disease: Promising Diagnostic and Therapeutic Biomarkers.

Tong Y, Zhang S, Riddle S, Song R, Yue D Biomolecules. 2023; 13(3).

PMID: 36979468 PMC: 10046088. DOI: 10.3390/biom13030533.


Characterization of the circRNA-miRNA-mRNA Network to Reveal the Potential Functional ceRNAs Associated With Dynamic Changes in the Meat Quality of the Longissimus Thoracis Muscle in Tibetan Sheep at Different Growth Stages.

Bao G, Zhao F, Wang J, Liu X, Hu J, Shi B Front Vet Sci. 2022; 9:803758.

PMID: 35433904 PMC: 9011000. DOI: 10.3389/fvets.2022.803758.

References
1.
Wagner A . Genes regulated cooperatively by one or more transcription factors and their identification in whole eukaryotic genomes. Bioinformatics. 2000; 15(10):776-84. DOI: 10.1093/bioinformatics/15.10.776. View

2.
Meng J, Chen S, Han J, Qian B, Wang X, Zhong W . Twist1 Regulates Vimentin through Cul2 Circular RNA to Promote EMT in Hepatocellular Carcinoma. Cancer Res. 2018; 78(15):4150-4162. DOI: 10.1158/0008-5472.CAN-17-3009. View

3.
You X, Vlatkovic I, Babic A, Will T, Epstein I, Tushev G . Neural circular RNAs are derived from synaptic genes and regulated by development and plasticity. Nat Neurosci. 2015; 18(4):603-610. PMC: 4376664. DOI: 10.1038/nn.3975. View

4.
Jiang Y, Qian F, Bai X, Liu Y, Wang Q, Ai B . SEdb: a comprehensive human super-enhancer database. Nucleic Acids Res. 2018; 47(D1):D235-D243. PMC: 6323980. DOI: 10.1093/nar/gky1025. View

5.
Hnisz D, Abraham B, Lee T, Lau A, Saint-Andre V, Sigova A . Super-enhancers in the control of cell identity and disease. Cell. 2013; 155(4):934-47. PMC: 3841062. DOI: 10.1016/j.cell.2013.09.053. View